Sean McClain skipped traditional academic route after graduating college, instead co-founding AbSci in 2011. AbSci is a synthetic biology company that uses genetically modified E.Coli bacteria to produce useful proteins, with a current focus on working with insulin manufacturers to accelerate production.

Biology Biologists, Technology, Technology, Science, Science and Technology Professionals, Life Sciences, Innovation, Health,